Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim F Greten

Showing results (151-160 of 223) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Investigation|November 13, 2013
Peptidases released by necrotic cells control CD8+ T cell cross-primingJaba Gamrekelashvili, Tamar Kapanadze, Miaojun Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2023
CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18Chi Ma, Justin McCallen, John C McVey, et al.
Cell Death & Disease|May 26, 2018
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4<sup>+</sup> T cell apoptosis promoting HCC developmentZachary J Brown, Qiong Fu, Chi Ma, et al.
Gut|November 19, 2017
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinomaAlexander Gerbes, Fabien Zoulim, Herbert Tilg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trialHelmut Oettle, Hanno Riess, Jens M Stieler, et al.
Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Cancer Cell|October 12, 2016
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor ProgressionTobias Eggert, Katharina Wolter, Juling Ji, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survivalTimm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
Journal of Hepatology|January 17, 2012
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalysesJean-Luc Raoul, Jordi Bruix, Tim F Greten, et al.
Cell Reports. Medicine|January 27, 2024
Lineage and ecology define liver tumor evolution in response to treatmentMahler Revsine, Limin Wang, Marshonna Forgues, et al.
Pageof 23

Showing results (151-160 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|November 13, 2013
Peptidases released by necrotic cells control CD8+ T cell cross-primingJaba Gamrekelashvili, Tamar Kapanadze, Miaojun Han, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2023
CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18Chi Ma, Justin McCallen, John C McVey, et al.
Cell Death & Disease|May 26, 2018
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4<sup>+</sup> T cell apoptosis promoting HCC developmentZachary J Brown, Qiong Fu, Chi Ma, et al.
Gut|November 19, 2017
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinomaAlexander Gerbes, Fabien Zoulim, Herbert Tilg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trialHelmut Oettle, Hanno Riess, Jens M Stieler, et al.
Journal for Immunotherapy of Cancer|January 6, 2024
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trialKelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, et al.
Cancer Cell|October 12, 2016
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor ProgressionTobias Eggert, Katharina Wolter, Juling Ji, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survivalTimm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
Journal of Hepatology|January 17, 2012
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalysesJean-Luc Raoul, Jordi Bruix, Tim F Greten, et al.
Cell Reports. Medicine|January 27, 2024
Lineage and ecology define liver tumor evolution in response to treatmentMahler Revsine, Limin Wang, Marshonna Forgues, et al.
Pageof 23